에 대한 최신 뉴스 Avantor (NYSE:AVTR) 주식

Avantor

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.

News

Movers

AVTR

CBRE

ENPH

FCNCA

LPLA

MANH

SIRI

SPOT

이들 11개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? QXO(NASDAQ:QXO)의 주가는 사모 금융 유치를 발표한 이후 33.37% 상승했다.

유니버셜 헬스 및 록히드 마틴은 지난주 최고 성과를 보여준 11개 대형주 중 일부 (7월 21일-7월 27일)

Avantor Inc

DA Davidson analyst Michael Baker maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Neutral and maintains $3025 price target.

Price Target

Analyst Ratings

DA Davidson Maintains Neutral on AutoZone, Maintains $3025 Price Target

Truist Securities analyst Neal Dingmann maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Buy and lowers the price target from $255 to $220.

FANG

Truist Securities Maintains Buy on Diamondback Energy, Lowers Price Target to $220

WIIM

SATS

EchoStar shares are trading lower. The company announced DirecTV will acquire its video business including Dish TV for a $11.7 billion debt exchange deal.

U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 200 points during on Monday.
Following the market opening Monday, the Dow traded down 0.55% to 42,079.06 while the NASDAQ rose 0.14% to 18,144.66. The S&amp;P 500 also fell, dropping, 0.14% to 5,730.18.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/09/41091653/how-to-earn-500-a-month-from-mccormick-stock-ahead-of-q3-earnings">How To Earn $500 A Month From McCormick Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Consumer staples shares jumped by 0.3% on Monday.
In trading on Monday, materials shares fell by 0.6%.
Top Headline
Carnival Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) posted better-than-expected quarterly earnings.
Carnival posted adjusted earnings of $1.27 per share, beating analysts' estimates of $1.16 per share. The company posted quarterly sales of $7.90 billion versus expectations of $7.83 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Kaixin Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) shares shot up 166% to $0.2397.</li>
<li>Shares of XChange TEC.INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) got a boost, surging 142% to $2.36.</li>
<li>EMCORE Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMKR#NASDAQ">EMKR</a>) shares were also up, gaining 73% to $2.08 after Mobix Labs submitted an all-cash offer to acquire the company for $3.80 per share.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Nano Labs Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares dropped 30% to $0.71.</li>
<li>Shares of YXT.COM Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) were down 25% to $2.80.</li>
<li>Plus Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) was down, falling 25% to $1.39.</li>
</ul>
Commodities In commodity news, oil traded down 0.2% to $68.05 while gold traded down 0.3% at $2,659.10.
Silver traded down 1.2% to $31.445 on Monday, while copper fell 0.8% to $4.5645.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.9%, Germany's DAX fell 0.6% and France's CAC 40 dipped 1.6%. Spain's IBEX 35 Index fell 0.6%, while London's FTSE 100 fell 0.5%.
The British economy grew by 0.5% on quarter during the second quarter, down from 0.7% in the first quarter, while the UK's current account deficit widened to £28.4 billion in the second quarter, versus a revised £13.8 billion in the prior quarter. Net consumer credit in the U.K. rose by £1.3 billion in August, from £1.2 billion in the previous month. German import prices increased by 0.2% year-over-year in August compared to a 0.9% rise in July.
Asia Pacific Markets
Asian markets closed mixed on Monday, with Japan's Nikkei 225 dipping 4.80%, Hong Kong's Hang Seng Index jumping 2.43%, China's Shanghai Composite Index gaining 8.06% and India's BSE Sensex falling 1.49%.
Japan&#8217;s housing starts fell by 5.1% year-over-year in August compared to a 0.2% decline in the prior month, while industrial production fell by 3.3% month-over-month in August. Retail sales in Japan climbed by 2.8% year-over-year in August.
The official NBS Non-Manufacturing PMI in China fell to 50.0 in September from 50.3 in the prior month, while official NBS Manufacturing PMI climbed to 49.8 in September from 49.1 in August.
Economics
The Chicago PMI rose to 46.6 in September from 46.1 in August versus market estimates of 46.2.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/41064318/top-3-real-estate-stocks-that-are-preparing-to-pump-this-month">Top 3 Real Estate Stocks That Are Preparing To Pump This Month</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Markets

Trading Ideas

EMKR

KXIN

PSTV

Dow Tumbles Over 200 Points; Carnival Posts Upbeat Earnings

New Fortress Energy Shares Halted On Circuit Breaker To The Downside, Stock Now Down -13.4%

DA Davidson analyst Michael Baker maintains A-Mark Precious Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) with a Buy and raises the price target from $47 to $52.

AMRK

DA Davidson Maintains Buy on A-Mark Precious Metals, Raises Price Target to $52

Truist Securities analyst Neal Dingmann maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Buy and lowers the price target from $60 to $49.

Truist Securities Maintains Buy on Devon Energy, Lowers Price Target to $49

ULCC

Frontier Group shares are trading higher after Raymond James upgraded the stock from Underperform to Market Perform.

Montrose Environmental Group shares are trading higher after Jehoshaphat Research announced they initiated a short position on the stock.

Nvidia CEO <a href="https://www.benzinga.com/topic/jensen-huang">Jensen Huang</a> got a first look at Meta&#8217;s new AR glasses and was impressed. At the recent Meta Connect <a href="https://www.youtube.com/watch?v=I7JyydkqDeI">event</a>, Mark Zuckerberg, the CEO of Meta, presented a reaction video that included Huang trying on the Orion prototype glasses. &#8220;The head tracking is good, the brightness is good, the color contrast is good, the field of view is excellent,&#8221; he said, calling the lightweight design &#8220;a big deal.&#8221;
Don't Miss:
<ul>
<li>General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
In the video, prominent figures in tech, media and even Olympians expressed excitement over the Orion glasses, describing them as &#8220;it&#8217;s crazy responsive,&#8221; &#8220;learning with these will be amazing,&#8221; and &#8220;it&#8217;s so fast.&#8221; Overall, the feedback seemed overwhelmingly positive.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Some of the reactions after <a href="https://twitter.com/search?q=%24META&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$META</a> unveils it&#39;s first AR holographic headset &quot;Orion&quot;. <a href="https://twitter.com/search?q=%24NVDA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$NVDA</a> Jensen Huang included in their reaction video. <a href="https://t.co/aAn8rvkzNM">pic.twitter.com/aAn8rvkzNM</a>
&mdash; Financial Berg (@FinancialBerg) <a href="https://twitter.com/FinancialBerg/status/1839017573590937892?ref_src=twsrc%5Etfw">September 25, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
These glasses are Meta's first attempt at a full holographic augmented reality device and Zuckerberg called them the &#8220;most advanced glasses the world has ever seen.&#8221;
Trending: Amid the ongoing EV revolution, previously overlooked low-income communities<a href="https://www.benzinga.com/money/dunamis-1"> now harbor a huge investment opportunity at just $500.</a>
Zuckerberg revealed that despite major technical obstacles, the team has worked on these glasses for 10 years. The goal was to create glasses with a wide field of view, that are lightweight and that allow users to see through them clearly – all while integrating cutting-edge technology. The result is a pair of glasses powered by a battery in the arm that bends light to generate realistic holograms of various sizes and depths using tiny projectors.
Even though Orion isn't available to the public yet and there's still work to be done, Meta is letting some external developers get their hands on the prototype. The company is also focusing on refining the design and lowering prices before launching a consumer version.
Trending: Teens may never need wisdom teeth removed thanks to this MedTech Company –<a href="https://www.benzinga.com/money/triagenics"> Be an early investor for just $300 for 100 shares!</a>
Given that <a href="https://www.benzinga.com/markets/24/09/41030350/no-task-is-beneath-me-how-nvidia-ceo-jensen-huang-became-one-of-the-worlds-richest-people">Nvidia is among the leading businesses in the IT industry</a>, Jensen Huang&#8217;s praise is noteworthy. Its GPUs are essential for AI and AR applications and Meta has been a massive client, stockpiling Nvidia&#8217;s technology to power its ambitious AI projects. By the end of 2024, Meta expects to have nearly 600,000 GPUs in its arsenal, so Huang's positive feedback carries extra weight.
<a href="https://www.benzinga.com/news/24/09/40931686/elon-musk-agrees-with-nvidia-ceo-jensen-huangs-vision-of-a-future-where-well-have-our-own-ai-powered">Huang recently talked about a future</a> where smart digital assistants would be with us throughout our lives, learning and growing alongside us. He's excited about having a computer that gets smarter over time, helping with daily tasks like having your own personal R2-D2 or C-3PO.
&#8220;I love the idea that I'll have my own R2-D2, my own C3PO and my R2 will be following me,&#8221; he stated, adding, &#8220;People who are just growing up now they're going to have their own personal R2 with them.&#8221;
Read Next
<ul>
<li>Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.</li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Startups

'This Is A Big Deal,' Says Jensen Huang As Nvidia CEO Tries On And Raves About Meta's New 'Orion' AR Glasses

Carnival CEO Says All Demand Indicators Continue To Move In The Right Direction

Truist Securities analyst Neal Dingmann maintains Crescent Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) with a Buy and lowers the price target from $19 to $15.

CRGY

Truist Securities Maintains Buy on Crescent Energy, Lowers Price Target to $15

New Fortress Energy Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) (&quot;NFE&quot; or the &quot;Company&quot;) today announced that the Company has determined to delay the payment of the Company&#39;s previously declared&nbsp;$0.10&nbsp;per share Class A common stock dividend, with a record date of September 13, 2024 (the &quot;Dividend&quot;), until such time as the Company has reached an agreement with its noteholders to address the Company&#39;s near-term maturities and liquidity requirements. The Company expects to reach an agreement with its noteholders in the near future, after which the Company will reevaluate the payment of the Dividend, including with respect to its amount and the timing of any potential payment

Dividends

New Fortress Energy Says Determined To Delay Payment Of Co's Previously Declared $0.10 Per Share Class A Common Stock Dividend

Cantor Fitzgerald analyst Andres Sheppard reiterates Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) with a Overweight and maintains $6 price target.

Reiteration

Cantor Fitzgerald Reiterates Overweight on Redwire, Maintains $6 Price Target

Macro Economic Events

Market Summary

Economics

General

BABA

STLA

Benzinga Market Summary: Chinese Stocks Continue Higher Amid Stimulus Measures, Autos Drop On Weak Stellantis Guidance

William Blair analyst Matt Phipps initiates coverage on Tenax Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENX#NASDAQ">TENX</a>) with a Outperform rating.

Initiation

TENX

William Blair Initiates Coverage On Tenax Therapeutics with Outperform Rating

<a href="https://www.latimes.com/california/story/2024-09-28/california-naloxone-first-aid-kits">https://www.latimes.com/california/story/2024-09-28/california-naloxone-first-aid-kits</a>
Workplaces in California could eventually be required to stock their first aid kits with naloxone or another medication that can stop an opioid overdose under <a href="https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=202320240AB1976">a bill</a> signed this week by Gov. Gavin Newsom.
Naloxone, commonly sold under the brand name Narcan, can prevent someone from dying of an opioid overdose if administered promptly by a bystander. The medicine binds to the same receptors in the brain as opioids such as fentanyl, which allows the medicine to displace the opioids and reverse their effects.
Assembly Bill 1976 requires California regulators to craft rules requiring first aid kits in workplaces to contain naloxone or any similar medication approved by the Food &amp; Drug Administration. Such a proposal would have to go before a state board for possible adoption by Dec. 1, 2028.
The bill was <a href="https://www.latimes.com/california/story/2024-01-31/to-prevent-opioid-overdoses-california-bill-would-require-naloxone-in-workplace-first-aid-kits">proposed by Assemblymember Matt Haney</a> (D-San Francisco) and supported by the California Emergency Nurses Assn. and a long list of law enforcement groups. Haney argued that it would dramatically increase the accessibility of naloxone, enabling more lives to be saved.
"If fentanyl continues to be more accessible than naloxone, we're going to keep seeing an increase in overdose deaths in our communities," he said in a statement.
Earlier this summer, AB 1976 was opposed by the National Electrical Contractors Assn. and other groups tied to the construction industry. The groups argued that the decision should be left to the Occupational Safety and Health Standards Board, which could decide whether a mandate made sense for all employers. For instance, they raised concerns about storing Narcan safely at construction sites that are not temperature controlled.
In recent months, however, the bill was amended to only require the Occupational Safety and Health Board to consider such a proposal — not to mandate that such rules be adopted. After that and other changes, NECA and other industry groups dropped their opposition, according to a lobbyist for its California chapter.
The state board focused on occupational safety has already been weighing the idea: Earlier this year, it reviewed a petition from the National Safety Council, a group that aims to eliminate leading causes of preventable deaths, to require employers to provide naloxone at all work sites.
Cal/OSHA concluded that doing so would lead to a "significant reduction in opioid-related deaths in California," with deadly injuries resulting from overdoses at work having risen between 2018 and 2022 from 23 to 117, according to a <a href="https://www.dir.ca.gov/oshsb/documents/petition-602-adopteddecision.pdf">state report</a>. But staff of the Occupational Safety and Health Board cautioned that mandating naloxone in workplace first aid kits could be "unnecessarily burdensome" for some employers.
The state board <a href="https://www.dir.ca.gov/oshsb/documents/petition-602-adopteddecision.pdf">decided</a> that exceptions could be made for employers who face practical barriers to storing or administering the medication. In June, it asked Cal/OSHA to convene an advisory committee to consider changing the state rules in order to require "ready access by employees to opioid antagonists."
AB 1976 will push that process along, advocates said, by setting a deadline for the board to consider such changes.

Biotech

Politics

'Newsom Signs Bill Pushing For Narcan In Workplace First Aid Kits' - LA Times

Cantor Fitzgerald analyst Andres Sheppard reiterates Polestar Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) with a Overweight and maintains $3 price target.

PSNY

Cantor Fitzgerald Reiterates Overweight on Polestar Automotive, Maintains $3 Price Target

Diversified Healthcare Trust shares are trading higher after the company announced it will sell 18 senior living communities to Brookdale Senior Living for $135 million.

Global

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

U.S. Officials Confirm Israeli Raids Inside Lebanon

Invesco Small Cap Value Fund Q2 2024 Review

Avantor to sell clinical services business to Audax in $650M deal

These are the stocks with the largest changes in short interest in July - GS

HYT: This Is A Decent Junk Bond Fund, But It Does Not Deserve Its Current Premium

The Broyhill Q2 2024 Letter

Broyhill's Q2 2024 Top Five Investments

Overweight quality stocks with positive EPS revision - MS

Overweight quality stocks with positive EPS revisions - MS

RBC Capital analyst Conor McNamara maintained a Buy rating on Avantor (AVTR – Research Report) on September 22 and set a price target of $34.00. Th...

Avantor (AVTR) Receives a Buy from RBC Capital

RBC Capital analyst Conor McNamara maintained a Buy rating on Avantor (AVTR – Research Report) yesterday and set a price target of $34.00. The comp...

RBC Capital Reaffirms Their Buy Rating on Avantor (AVTR)

AAPL

ABBV

ACGL

ADPPF

ALAB

ALLY

AMBP

AMZN

ANET

ATGE

BALL

BIIB

BIRK

BRBR

BURL

CART

CFLT

CHRD

COHR

CSTM

CVNA

DASH

DAVA

EPAM

EWBC

EXPE

FTNT

GLPI

GOOGL

HBAN

HUBS

JELD

LITE

LUMN

MASI

MDGL

MTDR

NFLX

NINE

NTDOF

NTDOY

NTRA

NVDA

PACS

QRVO

REGN

RYAN

SAIA

SIMO

SMCI

SMMT

SPWRQ

SRPT

TMUS

VERX

VICI

WELL

WFRD

Press Releases

Avantor® Reports Second Quarter 2024 Results

Wheels Up Announces Gregory Summe to Join Board of Directors

Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity

Audax Private Equity to Acquire Avantor's Clinical Services Business

Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance

Avantor® Participates in BioProcess International 2024 Conference Scientific Program and Exhibition

Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase Agreement

Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024

Avantor® Wins Kaizen Institute Award for Excellence in Process Improvement and Quality Management

GRAL

NXPI

Agilent Technologies

AbCellera Biologics

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

Charles River Laboratories International, Inc. Common Stock

Charles River

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Avantor

뉴스

에 대한 최신 뉴스 Avantor (NYSE:AVTR) 주식

일요일, 7월 28, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌